Thyroid Cancer
FDA grants breakthrough therapy designation to Cabometyx for thyroid cancer subset
‘Overdiagnosis’ driving increased thyroid cancer incidence in children
Thyroid disorders before, during pregnancy raise thyroid cancer risk in children
FDA approves Gavreto for RET-altered thyroid cancers
Study data support higher-dose lenvatinib for radioactive iodine-refractory thyroid cancer
Lenvatinib monotherapy fails to improve survival in anaplastic thyroid cancer
'Pressing need' for quality data on treatment options for low-risk thyroid cancers

Models projecting incidence of low-risk papillary thyroid cancers suggest there will be more than 200,000 new thyroid cancer diagnoses during the next 5 years, with at least 67,000 of those cases qualifying as candidates for active surveillance due to small tumor size, according to findings published in JAMA Otolaryngology Head & Neck Surgery.
'Consistent increase' observed in larger, more aggressive thyroid tumors in California

A retrospective analysis of diagnosed thyroid cancer cases in California revealed a consistent increase in the diagnosis of larger and more aggressive thyroid tumors that correlated with a rise in incidence-based mortality among men and individuals with tumors larger than 1 cm, according to findings published in The Journal of Clinical Endocrinology & Metabolism.